Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: Endometrioma

In brief

The aim of this study is to determine whether or not continuous combined oral contraceptive pills (COCP's) decrease the risk of recurrent endometrioma formation. The investigators' hypothesis is that patients who have endometriomas surgically removed and then are started on COCP's will have a decreased incidence of recurrent endometrioma formation. The investigators' research protocol is designed to show a statistically significant decreased incidence of endometrioma formation in the hopes that physicians will use COCP's in patients they have removed an endometrioma in who do not desire immediate fertility. Long term, the investigators hope to establish a standard of care that COCP's be used postoperatively in appropriate candidates to decrease the chance of recurrent endometrioma formation.

Key facts

Study ID

NCT00999479

Run by

University of Oklahoma

People needed

0

Starts

2009-10-01

Expected to finish

2011-10-01

Last updated by the study team

2013-12-10

Who can join

Age: 18 and older, up to 35. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Patients with a diagnosis of ovarian endometriotic cyst that has been surgically excited.

You may not qualify if…

• Current desire to achieve pregnancy or other contraindication to combined oral contraceptive pills.

Where it is running

• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.